Saudi Arabia Biotechnology Market Size to Hit USD 11,604 Million by 2033, At CAGR 5.66%

Saudi Arabia Biotechnology Market Overview

Market Size in 2024: USD 7,067 Million

Market Size in 2033: USD 11,604 Million

Market Growth Rate 2025-2033: 5.66%

According to IMARC Group's latest research publication, "Saudi Arabia Biotechnology Market Size, Share, Trends and Forecast by Product Type, Technology, Application, and Region, 2025-2033", The Saudi Arabia biotechnology market size was valued at USD 7,067 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 11,604 Million by 2033, exhibiting a CAGR of 5.66% from 2025-2033.

Download a sample PDF of this report: https://www.imarcgroup.com/saudi-arabia-biotechnology-market/requestsample

How AI and Digital Transformation is Reshaping the Future of Saudi Arabia Biotechnology Market

• AI-powered genomics analysis in Saudi Arabia has accelerated sequencing of over 65,000 genomes, revealing new insights for personalized healthcare.
• Machine learning algorithms are optimizing biopharmaceutical production, improving yield and reducing development time by up to 25 percent in local labs.
• AI-based diagnostic tools are enhancing early disease detection, with pilot programs at major hospitals showing diagnostic accuracy increases of 15-20 percent.
• Government-backed AI initiatives are fostering biotech innovation hubs that integrate data analytics and robotics, boosting R&D productivity across Saudi research centers.
• AI-driven precision agriculture solutions are enabling genetic modification of crops for drought tolerance, supporting Saudi Arabia’s sustainable food security goals.

Saudi Arabia Biotechnology Market Trends & Drivers:

Saudi Arabia’s biotechnology market is being propelled by the National Biotechnology Strategy under Vision 2030, which focuses on establishing the Kingdom as a global biotech hub. This strategy is fueling investments in biomanufacturing, vaccine development, and genomics, with initiatives such as the Saudi Human Genome Program sequencing over 65,000 individuals. Significant government backing is also supporting innovation zones and research centers like KAUST and KAIMRC, helping Saudi companies excel in precision medicine and biopharmaceutical production while aligning healthcare industry growth with national economic diversification.

Another major growth driver is the rising healthcare demand amid increasing chronic diseases, which boosts biopharmaceuticals and precision medicine in Saudi Arabia. New treatments like CAR T-cell therapy are being localized in specialist hospitals, reducing treatment costs by up to 80%, and increasing patient accessibility. This surge is also encouraging biotech startups and international partnerships focused on gene therapies, diagnostic tools, and advanced medical technologies, giving Saudi Arabia an advantage in cutting-edge health solutions that improve outcomes and reduce dependency on imports.

Sustainable agriculture and environmental biotech are emerging trends gaining momentum as Saudi Arabia aims to enhance food security and address arid climate challenges. AI-driven genetic engineering is creating drought-resistant crops, while bioremediation technologies tackle soil and water pollution. Growing focus on renewable bioenergy and waste management also opens new market segments aligned with Vision 2030’s sustainability goals. Partnerships between public institutions and private players are accelerating R&D in these areas, underlining biotechnology’s strategic role beyond healthcare in supporting Saudi Arabia’s long-term economic and environmental resilience.

Ask analyst for customized report: https://www.imarcgroup.com/request?type=report&id=21030&flag=E

Saudi Arabia Biotechnology Industry Segmentation:

The report has segmented the market into the following categories:

Breakup by Product Type:

• Instruments
• Reagents
• Software and Services

Breakup by Technology:

• Nanobiotechnology
• Tissue Engineering and Regeneration
• DNA Sequencing
• Cell-Based Assays
• Fermentation
• PCR Technology
• Chromatography
• Others

Breakup by Application:

• Healthcare
• Food and Agriculture
• Natural Resources and Environment
• Industrial Processing
• Bioinformatics
• Others

Breakup by Region:

• Northern and Central Region
• Western Region
• Eastern Region
• Southern Region

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Recent News and Developments in Saudi Arabia Biotechnology Market

• Nov 2025: Saudi’s $50 million biotech fund launched to accelerate advanced drug development and local manufacturing, boosting research pipelines and startups.
• Sep 2025: KAUST unveiled AI-driven platforms for precision medicine that improve genetic data analysis speed by 40%, enabling tailored therapies.
• Jul 2025: Ministry of Health introduced a new biopharma pilot program, reducing treatment costs by 30% with locally produced biologics for chronic diseases.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-201971-6302